Cost-benefit analysis for the therapy of bile tract infections - Comparison of ceftriaxone versus "standard therapy".

被引:0
|
作者
Zoepf, T
Kullmann, KH
Jakobs, R
Riemann, JF
机构
[1] Clin Ludwigshafen, Dept Med C, Ludwigshafen, Germany
[2] Hoffmann La Roche, Grenzach Wyhlen, Germany
关键词
D O I
10.1016/S0016-5085(00)83404-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1784
引用
收藏
页码:A328 / A328
页数:1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF ERTAPENEM VERSUS CEFTRIAXONE IN TREATING URINARY TRACT INFECTIONS IN COLOMBIA
    Xie, Y.
    Lemos, E.
    Restrepo, M.
    Ruiz, J.
    Lozano, F.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A274 - A274
  • [42] Cost-benefit analysis of the Mandatory Standard for wastewater discharge to water bodies
    Rojas, F
    Serhan, G
    Volantin, S
    [J]. INGENIERIA HIDRAULICA EN MEXICO, 1997, 12 (01): : 27 - 40
  • [43] COST-EFFECTIVENESS OF PHARMACEUTICALS .5. COST-BENEFIT AND COST-EFFECTIVENESS ANALYSIS OF DRUG-THERAPY
    DAO, TD
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1985, 42 (04): : 791 - 802
  • [44] A comparison of frequentist and Bayesian statistical approaches in cost-benefit analysis
    Blizzard, J
    Michels, J
    Reeder, CE
    Lingle, EE
    Schulz, RM
    Bradford, WD
    [J]. VALUE IN HEALTH, 2005, 8 (06) : A181 - A181
  • [45] Cost-effectiveness comparison of sequential ofloxacin versus standard switch therapy
    Partsch, DJ
    Paladino, JA
    [J]. ANNALS OF PHARMACOTHERAPY, 1997, 31 (10) : 1137 - 1145
  • [46] Cost-benefit of antenatal glucocorticoid therapy: There is still much more to learn
    Nathanielsz, Peter W.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2023, 130 (04) : 334 - 335
  • [47] Levofloxacin versus Ceftriaxone as therapy of acute cholangitis a prospective comparison
    Kiesslich, R
    Holfelder, M
    Will, D
    Hahn, M
    Nafe, B
    Maeurer, M
    Jung, M
    [J]. GASTROINTESTINAL ENDOSCOPY, 2001, 53 (05) : AB109 - AB109
  • [48] Cost-effectiveness and cost-benefit analysis of using methotrexate vs Goeckerman therapy for psoriasis - A pilot study
    Chen, S
    Shaheen, A
    Garber, A
    [J]. ARCHIVES OF DERMATOLOGY, 1998, 134 (12) : 1602 - 1608
  • [49] AMIKACIN AND CEFTRIAXONE AS 1ST-LINE THERAPY FOR SEVERE URINARY-TRACT INFECTIONS IN ADULTS - A COMPARISON
    LEPAGE, JY
    JUGE, C
    COZIAN, A
    ESPAZE, E
    REYNAUD, AE
    SOURON, R
    BARON, D
    [J]. PATHOLOGIE BIOLOGIE, 1987, 35 (05): : 638 - 641
  • [50] NEW ALL ORAL THERAPY FOR CHRONIC HEPATITIS C VIRUS (HCV): A COST-BENEFIT ANALYSIS
    Orsi, J.
    Einodshofer, M.
    Kirkham, H.
    Glover, P.
    DuChane, J.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A37 - A37